Case Study

Sponsor Generates Significant Savings By Proactively Managing Value Added Tax (VAT) In Global Trials

Source: DrugDev

Significant opportunity exists to reduce cost and improve cash flow by properly managing this line item within your Clinical Trial. Surprisingly, we have found most sponsors/CROs are not doing any upfront planning or ongoing management of the Value Added Tax (VAT) costs relating to their clinical trials.  VAT rates can range from 10% to 30% of the visit fees paid to the sites and add a significant cost to the trial. With some proactive planning, these costs can often be avoided, eliminating the time consuming process of recovering VAT, or correcting charges made in error by the site due to confusion surrounding local VAT rules and regulations.  Consider VAT taxes as you develop your contracting structure by country and implement the appropriate controls to validate site invoices throughout the life of the trial.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader